SCHEMBL4539675

SCHEMBL4539675

COc1ccc(CCCn2ccnc2)cc1OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.69
CYP1A2 P05177 1/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
TSHR P16473 1/20 0.69
NFKB1 P19838 1/20 0.69
CYP2C19 P33261 1/20 0.69
MTOR P42345 1/20 0.69
RAB9A P51151 1/20 0.69
HIF1A Q16665 1/20 0.69
QPCT Q16769 8/20 0.67
MEN1 O00255 1/20 0.67
GMNN O75496 1/20 0.67
LMNA P02545 1/20 0.67
MAPT P10636 1/20 0.67
BLM P54132 1/20 0.67
PMP22 Q01453 1/20 0.67
KMT2A Q03164 1/20 0.67
TDP1 Q9NUW8 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5757028 0.88 TSHR (0.58) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5758544 0.87 CYP1A2 (0.58) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL19786271 0.83 QPCT (0.58) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL19766926 0.82 QPCT (0.59) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL12845734 0.82 TP53 (0.60) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL10508142 0.81 MEN1 (0.69) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL76179 0.81 QPCT (1.00) QPCTQPCTLALDH1A1
SCHEMBL5759435 0.79 MAPK1 (0.58) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL16350670 0.79 QPCT (0.77) TSHRQPCTMEN1MAPTKMT2A
SCHEMBL19766927 0.79 QPCT (0.53) TP53CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117540-A1 NEW USE OF GLUTAMINYL CYCLASE INHIBITORS Probiodrug AG (DE) 2009-11-18 EP disclosed
WO-2008104580-A1 NEW USE OF GLUTAMINYL CYCLASE INHIBITORS PROBIODRUG AG (DE) 2008-09-04 WO disclosed